Immunophenotypic characterization of NF-κB expression in the dentate gyrus of aging rats with diabetes mellitus and its pharmacological correction
Open Access
- 7 April 2026
- journal article
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (1) , 109-114
Abstract
Introduction: The study is devoted to studying the expression level of the transcription factor NF-kB in the dentate gyrus of rats, which acts as one of the key mediators in the pathogenesis of neuroinflammation and neurodegeneration associated with diabetes mellitus. The aim of the study was to characterize the expression of NF-kB in the dentate gyrus of 19-month-old rats using a model of diabetes and to evaluate the modulating effect of pharmacological agents (mefargine, aminalon, and succicard). Materials and methods: in aging rats aged 12 months, type 1 diabetes mellitus (DM) was modeled for 6 months by a single injection of streptozotocin (Sigma, USA) dissolved in citrate buffer (0.1 M, pH 4.5) at a dose of 60 mg/kg after 48 hours of food deprivation intraperitoneally. After reaching the age of 18 months, the animals were injected with GABA derivatives for 4 weeks: mefargine, aminalon and succicard. NF-kB was detected by immunohistochemical examination using primary antibodies to the NF-kB protein on paraffin frontal sections of the rat brain. Results: An immunohistochemical study revealed an increase in the expression of NF-kB, an immunoreactive material in the cytoplasm of pericaryons of neurons and the neuropile of the granular and subgranular layers in the dentate gyrus in rats with DM compared with intact animals, reflecting a profound violation of cellular homeostasis and activation of neuroinflammation in brain structures. Cells with a moderate expression level appeared in the cytoplasm of the pericaryons of the neurons of the granular layer, as well as in the neuropile of the granular layer and in the nerve cells of the subgranular layer. Whereas in the intact group, only a few cells had a weak expression level. In animals with DM, which were injected with the studied compounds (aminalon, mefargine, succicard), the expression of NF-kB-immunoreactive material decreased compared with the DM group without treatment. The restorative effect of the studied drugs confirms the expediency of their use for the correction of metabolic disorders in the brain in diabetes mellitus and aging.Keywords
This publication has 13 references indexed in Scilit:
- Paeoniflorin exercise-mimetic potential regulates the Nrf2/HO-1/BDNF/CREB and APP/BACE-1/NF-κB/MAPK signaling pathways to reduce cognitive impairments and neuroinflammation in amnesic mouse modelBiomedicine & Pharmacotherapy, 2025
- Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFĸB in neurodegenerative diseaseInflammopharmacology, 2025
- Morphofunctional changes in cerebral motor cortex in experimental type I diabetes mellitusJournal of Anatomy and Histopathology, 2024
- Ripks and NeuroinflammationMolecular Neurobiology, 2024
- Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairmentAutophagy, 2023
- Effects of diabetes on apoptosis and mitosis in rat hippocampusBiotechnic & Histochemistry, 2020
- Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar ratsLipids in Health and Disease, 2018
- Synaptic NF-kappa B pathway in neuronal plasticity and memoryJournal of Physiology-Paris, 2014
- A Requirement for Nuclear Factor-κB in Developmental and Plasticity-Associated SynaptogenesisThe Journal of Neuroscience, 2011
- NF-κB in the Survival and Plasticity of NeuronsNeurochemical Research, 2005